# Pharmacokinetics/Pharmacodynamics of Albiglutide

> **NCT01357889** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 283 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **BIOLOGICAL:** albiglutide (GSK716155)
- **BIOLOGICAL:** albiglutide (GSK716155)

## Key facts

- **NCT ID:** NCT01357889
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357889, "Pharmacokinetics/Pharmacodynamics of Albiglutide". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01357889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*